論文・総説 - 田中　真二

81. Shimada Shu, Tanaka Shinji. 多段階発癌の遺伝的進化の理解の新時代(A new era for understanding genetic evolution of multistep carcinogenesis) Journal of Gastroenterology. 2019.07; 54 (7): 667-668. ( 医中誌 )

82. Ban Daisuke, Kudo Atsushi, Tanaka Shinji, Tanabe Minoru. HBP外科専門医への教育ロードマップ　腹腔鏡下HBP外科専門医へのロードマップ(Education roadmap to qualified HBP surgeons　Roadmap to the qualified laparoscopic HBP surgeon) 日本肝胆膵外科学会・学術集会プログラム・抄録集. 2019.06; 31回 ESY1-1. ( 医中誌 )

83. Fukamachi Hiroshi, Kim Seon-Kyu, Koh Jiwon, Lee Hye Seung, Sasaki Yasushi, Yamashita Kentaro, Nishikawaji Taketo, Shimada Shu, Akiyama Yoshimitsu, Byeon Sun-ju, Bae Dong-Hyuck, Okuno Keisuke, Nakagawa Masatoshi, Tanioka Toshiro, Inokuchi Mikito, Kawachi Hiroshi, Tsuchiya Kiichiro, Kojima Kazuyuki, Tokino Takashi, Eishi Yoshinobu, Kim Yong Sung, Kim Woo Ho, Yuasa Yasuhito, Tanaka Shinji. A subset of diffuse-type gastric cancer is susceptible to mTOR inhibitors and checkpoint inhibitors JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2019.03; 38 (1): 127. ( PubMed, DOI )

84. Shimada Shu, Mogushi Kaoru, Akiyama Yoshimitsu, Furuyama Takaki, Watanabe Shuichi, Ogura Toshiro, Ogawa Kosuke, Ono Hiroaki, Mitsunori Yusuke, Ban Daisuke, Kudo Atsushi, Arii Shigeki, Tanabe Minoru, Wands Jack R., Tanaka Shinji. Comprehensive molecular and immunological characterization of hepatocellular carcinoma EBIOMEDICINE. 2019.02; 40 457-470. ( PubMed, DOI )

85. Okuno Keisuke, Akiyama Yoshimitsu, Shimada Shu, Nakagawa Masatoshi, Tanioka Toshiro, Inokuchi Mikito, Yamaoka Shoji, Kojima Kazuyuki, Tanaka Shinji. Asymmetric dimethylation at histone H3 arginine 2 by PRMT6 in gastric cancer progression CARCINOGENESIS. 2019.01; 40 (1): 15-26. ( PubMed, DOI )

86. Ishikawa Y, Ban D, Watanabe S, Akahoshi K, Ono H, Mitsunori Y, Kudo A, Tanaka S, Tanabe M. Splenic artery as a simple landmark indicating difficulty during laparoscopic distal pancreatectomy. Asian journal of endoscopic surgery. 2019.01; 12 (1): 81-87. ( PubMed, DOI )

87. Watanabe Yuichiro, Honda Shinya, Konishi Akimitsu, Tanabe Minoru, Tanaka Shinji, Shimizu Shigeomi. Autophagy controls centrosome number by degrading Cep63 CANCER SCIENCE. 2018.12; 109 309.

88. Shimada Shu, Akiyama Yoshimitsu, Tanabe Minoru, Tanaka Shinji. FABP4 overexpression in intratumoral hepatic stellate cells within hepatocellular carcinoma with metabolic risk factors CANCER SCIENCE. 2018.12; 109 940.

89. Fukamachi Hiroshi, Nishikawaji Taketo, Shimada Shu, Akiyama Yoshimitsu, Yuasa Yasuhito, Tsuchiya Kiichiro, Tanaka Shinji. Diffuse-type gastric cancers are classified into two clusters, which may be formed via different carcinogenic pathways CANCER SCIENCE. 2018.12; 109 1131.

90. Mizuno Yuki, Shimada Shu, Akiyama Yoshimitsu, Watanabe Shuichi, Aida Tomomi, Ogawa Kosuske, Ono Hiroaki, Mitsunori Yusuke, Ban Daisuke, Kudo Atsushi, Yamaoka Shoji, Tanaka Shinji, Tanabe Minoru. DEPDC5 deficiency contributes to resistance to leucine starvation via p62 accumulation in hepatocellular carcinoma CANCER SCIENCE. 2018.12; 109 952.

91. Akiyama Yoshimitsu, Shimada Shu, Tanabe Minoru, Tanaka Shinji. DAXX acts as a tumor suppressor through histone H3.3/H3K9me3 pathway in pancreatic neuroendocrine tumors CANCER SCIENCE. 2018.12; 109 1103.

92. Tanaka Shinji. Molecular target therapy for liver cancer under precision medicine CANCER SCIENCE. 2018.12; 109 634.

93. Keiichi Akahoshi, Hiroaki Ono, Masafumi Akasu, Daisuke Ban, Atsushi Kudo, Atsuko Konta, Shinji Tanaka, Minoru Tanabe. Rapid growth speed of cysts can predict malignant intraductal mucinous papillary neoplasms Journal of Surgical Research. 2018.11; 231 195-200.

94. Keiichi Akahoshi、Daisuke Ban, Ryo Kuboki, Atsushi Oba, Hiroaki Ono, Yusuke Mitsunori, Atsushi Kudo, Shinji Tanaka and Minoru Tanabe. Orotate phosphoribosyltransferase as a predictor of benefit from S-1 adjuvant chemotherapy for cholangiocarcinoma patients Journal of Gastroenterology and Hepatology. 2018.09;

95. Kudo A, Akahoshi K, Ito S, Akashi T, Shimada S, Ogura T, Ogawa K, Ono H, Mitsunori Y, Ban D, Tateishi U, Tanaka S, Tanabe M.. Downregulated Pancreatic Beta Cell Genes Indicate Poor Prognosis in Patients With Pancreatic Neuroendocrine Neoplasms. Ann Surg.. 2018.07;

96. Ueda H, Akiyama Y, Shimada S, Mogushi K, Serizawa M, Matsumura S, Mitsunori Y, Aihara A, Ban D, Ochiai T, Kudo A, Tanabe M, Tanaka S.. Tumor suppressor functions of DAXX through histone H3.3/H3K9me3 pathway in pancreatic NETs. Endocr Relat Cancer. 2018.06; 25 (6): 619-631.

97. 松井　聡、伴　大輔、工藤　篤、田中真二、田邉　稔. 減量切除が有用であった血糖制御不能な悪性インスリノーマの1例 臨床外科. 2018.05; 79 (5): 138-144.

98. Norimichi Chiyonobu, Shu Shimada, Yoshimitsu Akiyama, Kaoru Mogushi, Michiko Itoh, Keiichi Akahoshi, Satoshi Matsumura, Kosuke Ogawa, Hiroaki Ono, Yusuke Mitsunori, Daisuke Ban, Atsushi Kudo, Shigeki Arii, Takayoshi Suganami, Shoji Yamaoka, Yoshihiro Ogawa, Minoru Tanabe, Shinji Tanaka. Fatty acid binding protein 4 (FABP4) overexpression in intratumoral hepatic stellate cells within hepatocellular carcinoma with metabolic risk factors The American Journal of Pathology. 2018.05; 188 (5):

99. Chiyonobu Norimichi, Shimada Shu, Akiyama Yoshimitsu, Mogushi Kaoru, Itoh Michiko, Akahoshi Keiichi, Matsumura Satoshi, Ogawa Kosuke, Ono Hiroaki, Mitsunori Yusuke, Ban Daisuke, Kudo Atsushi, Arii Shigeki, Suganami Takayoshi, Yamaoka Shoji, Ogawa Yoshihiro, Tanabe Minoru, Tanaka Shinji. Fatty Acid Binding Protein 4 (FABP4) Overexpression in Intratumoral Hepatic Stellate Cells within Hepatocellular Carcinoma with Metabolic Risk Factors AMERICAN JOURNAL OF PATHOLOGY. 2018.05; 188 (5): 1213-1224. ( PubMed, DOI )

100. Kawai-Kitahata F., Asahina Y., Kakinuma S., Murakawa M., Nitta S., Nagata H., Kaneko S., Inoue E., Miyoshi M., Tsunoda T., Sato A., Nakagawa M., Itsui Y., Azuma S., Tanaka S., Tanabe M., Maekawa S., Enomoto N., Watanabe M.. Difference of gene mutational profile among viral- and non-viral HCC with or without prior HBV infection: Results of comprehensive deep sequencing analyses of cancer genes and HBV/AAV integration JOURNAL OF HEPATOLOGY. 2018.04; 68 S667.